Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources

Fig. 1

Data source completeness assessment criteria. *Outcomes data received through direct contact were classified as good if the data source administrator confirmed its availability. BCVA, best-corrected visual acuity; IVIS, Impact of Visual Impairment Scale; VEGF, vascular endothelial growth factor; VFQ-25, 25-item Visual Function Questionnaire

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us